Annual Total Expenses
$35.25 M
-$1.52 M-4.13%
31 December 2022
Summary:
Zynerba Pharmaceuticals annual total expenses is currently $35.25 million, with the most recent change of -$1.52 million (-4.13%) on 31 December 2022. During the last 3 years, it has fallen by -$16.81 million (-32.29%).ZYNE Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$11.14 M
+$665.00 K+6.35%
30 June 2023
Summary:
Zynerba Pharmaceuticals quarterly total expenses is currently $11.14 million, with the most recent change of +$665.00 thousand (+6.35%) on 30 June 2023.ZYNE Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYNE Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -32.3% | +9.1% |
| 5 y5 years | -12.9% | +478.1% |
ZYNE Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -32.3% | -49.0% |
Zynerba Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $11.14 M(+6.4%) |
| Mar 2023 | - | $10.47 M(+20.6%) |
| Dec 2022 | $35.25 M(-4.1%) | $8.69 M(+2.3%) |
| Sept 2022 | - | $8.49 M(-7.4%) |
| June 2022 | - | $9.17 M(+3.0%) |
| Mar 2022 | - | $8.90 M(+0.8%) |
| Dec 2021 | $36.77 M(-29.4%) | $8.84 M(-13.5%) |
| Sept 2021 | - | $10.21 M(+3.8%) |
| June 2021 | - | $9.84 M(+24.8%) |
| Mar 2021 | - | $7.88 M(-22.6%) |
| Dec 2020 | $52.06 M(+51.7%) | $10.19 M(+10.4%) |
| Sept 2020 | - | $9.23 M(-57.7%) |
| June 2020 | - | $21.84 M(+102.3%) |
| Mar 2020 | - | $10.80 M(-5.4%) |
| Dec 2019 | $34.32 M(-15.2%) | $11.42 M(+492.7%) |
| Sept 2019 | - | $1.93 M(-83.3%) |
| June 2019 | - | $11.51 M(+21.6%) |
| Mar 2019 | - | $9.47 M(+16.4%) |
| Dec 2018 | $40.48 M | $8.13 M(+1.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $7.99 M(-33.3%) |
| June 2018 | - | $11.97 M(-3.4%) |
| Mar 2018 | - | $12.40 M(+51.1%) |
| Dec 2017 | $32.82 M(+41.4%) | $8.20 M(-4.0%) |
| Sept 2017 | - | $8.55 M(+2.2%) |
| June 2017 | - | $8.37 M(+8.6%) |
| Mar 2017 | - | $7.70 M(+15.2%) |
| Dec 2016 | $23.21 M(+81.2%) | $6.68 M(+11.5%) |
| Sept 2016 | - | $6.00 M(-4.6%) |
| June 2016 | - | $6.28 M(+47.9%) |
| Mar 2016 | - | $4.25 M(-22.3%) |
| Dec 2015 | $12.81 M(+97.8%) | $5.47 M(+30.3%) |
| Sept 2015 | - | $4.19 M(+155.4%) |
| June 2015 | - | $1.64 M(+9.0%) |
| Mar 2015 | - | $1.51 M(+2.0%) |
| Dec 2014 | $6.48 M(+310.4%) | $1.48 M(-51.4%) |
| Sept 2014 | - | $3.04 M(+93.2%) |
| June 2014 | - | $1.57 M(+308.3%) |
| Mar 2014 | - | $385.40 K |
| Dec 2013 | $1.58 M | - |
FAQ
- What is Zynerba Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Zynerba Pharmaceuticals?
What is Zynerba Pharmaceuticals annual total expenses?
The current annual total expenses of ZYNE is $35.25 M
What is the all time high annual total expenses for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high annual total expenses is $52.06 M
What is Zynerba Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of ZYNE is $11.14 M
What is the all time high quarterly total expenses for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high quarterly total expenses is $21.84 M